Jamal El Mosleh

Jamal El Mosleh discloses dealings in Annexin Pharmaceuticals AB (publ) to Finansinspektionen. The record holds 5 filings, for trades running from 19 March 2018 to 11 March 2019.

Every open-market trade on record is a purchase: 5 purchases worth €177k, and no sale. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2019 to date brings 1 purchase and no sales.

In size, the median ticket on the buying side is €45k. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 11 March 2019, reports an open-market purchase of €5,773 in Annexin Pharmaceuticals AB (publ). Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.